Kamila M. Ludwikowska

Assistant professor

Uniwersytet Medyczny im Piastów Śląskich we Wrocławiu

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kamila M. Ludwikowska is an Assistant Professor at Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu, Poland. Her research interests focus on pediatric cardiology and the clinical implications of multisystem inflammatory syndrome in children, particularly in the context of COVID-19. Recent publications explore the pathologic analysis of appendices in children and the immunogenicity of COVID-19 vaccines among those with a history of pediatric multisystem inflammatory syndrome.

Articles (12)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (15)

Mariusz Panczyk

PhD, PharmD., Assoc. Prof., Head of the Section of Evaluation and Improvement of Medical Education

Medical University of Warsaw

POLAND

Kamila M. Ludwikowska

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Pathologic Analysis of Twenty-one Appendices From Children With Multisystem Inflammatory Syndrome Compared to Specimens of Acute Appendicitis: A Cross-sectional Study

Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions

Cardiac Involvement in Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) in Poland

COVID-19 mRNA BNT162b2 vaccine safety and B-cell and T-cell reactogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS) - preliminary study

COVID-19 mRNA Vaccine Tolerance and Immunogenicity in Hematopoietic Stem Cell Transplantation Recipients Aged 5–11 Years Old–Non-Randomized Clinical Trial

COVID-19 mRNA BNT162b2 vaccine immunogenicity among children with a history of paediatric multisystem inflammatory syndrome temporally associated with COVID-19 (PIMS-TS)

Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study

A tendency to worse course of multisystem inflammatory syndrome in children with obesity: MultiOrgan Inflammatory Syndromes COVID-19 related study

Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome

Takotsubo syndrome as a cardiac manifestation of multisystem inflammatory syndrome in children

Guidelines for immunization of children following multisystem inflammatory syndrome in children

Approach to a child with Multisystem Inflammatory Syndrome associated with COVID19. Recommendations by the Polish Paediatric Society Expert Group. Update - February 2021

Collaborators (15)

Mariusz Panczyk

Marek Ussowicz

Leszek Szenborn

Aneta Afelt

Mateusz Sokolski

Catherine Suski Grabowski

Miron Bartosz Kursa

Wojciech Feleszko

KRZYSZTOF KALWAK

Lidia Stopyra

Aneta Popiel

Aleksandra Antosz

Joanna Owoc-Lempach

Artur Mazur

Lesław Szydłowski

Make your next move.